Aim: To find out the vocal outcome of conservative management and temporary medialization in unilateral vocal cord palsy (UVCP) and their effectiveness in reducing the need for permanent medialization. Materials and methods:Thirty adult patients with UVCP, without structural vocal cord lesion or laryngeal malignancy were initially treated conservatively, and those without adequate response at 3 months were treated with temporary medialization. They were followed up for 6 months. Pre-and posttreatment voice was compared using grade, roughness, breathiness, asthenia, strain (GRBAS) scale, Voice Handicap Index (VHI), and maximum phonation time (MPT). Results:The results show 40% cases were idiopathic, whereas 33.33% had iatrogenic cause, majority, following thyroidectomy; 66.67% responded well to the conservative management. Ten patients (33.33%) did not show satisfactory improvement in the first 3 months and were treated with temporary medialization. Both the groups were comparable at the first visit. At 6 months, the improvement in all parameters was significantly more in the temporary medialization group than the conservative management group compared with their values at 3 months. Two of the 10 patients treated with injection laryngoplasty were considered for permanent medialization. The final outcome was similar in both the groups. Conclusion:Conservative management of UVCP is the standard of care. Injection laryngoplasty at 3 months achieves better voice outcome in those not fully improved by conservative management. Medialization thyroplasty should be suggested in patients failing to show the desired improvement after injection laryngoplasty.Clinical significance: The study guides in the management of UVCP, in terms of its likely cause and approach to treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.